Betaxolol hydrochloride
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263149This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C18H29NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X97D2XT0O, chemically known as 2-propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)- but more generally known as betaxolol hydrochloride, which bears US NIH Compound Identifier 107952. European Medicines Agency schedules Betaxolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13062MIG. Most nations, for tariff and trade purposes, schedule betaxolol hydrochloride under HS 29221980. As of Q4 2014, BETAXOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Betaxolol hydrochloride bears US NLM identifiers UMLS ID C0699055 and NCI Concept Code C47413. SMILES: CC(C)NCC(COC1CCC(CC1)CCOCC2CC2)O.CL.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.